Guaifenesin 200mg
Product Images NDC 10135-681

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin 200mg (NDC 10135-681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelndc 10135-0681-01guaifenesin200 mg100 Tablets (Guaifenesin 200mg 01)

Label for Guaifenesin 200 mg tablets by Marlex Pharmaceuticals, Inc. The label indicates 100 tablets per container. The Drug Facts panel lists guaifenesin as the active ingredient and includes usage, warnings, and tamper-evident information. A barcode and NDC 10135-0681-01 are also visible.*

FDA Label Image

Principal Display Panelndc 10135-0681-01guaifenesin200 mg100 Tablets (Guaifenesin 200mg 02)

Drug Facts panel continuation for Guaifenesin 200mg by Marlex Pharmaceuticals Inc. Contains directions for use, including dosage limits for children over 12 years and adults, storage instructions at 15°-30°C (59°-86°F), and a list of inactive ingredients such as colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, povidone, and stearic acid.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.